Kirk, J.E., Matzke, J.R., Brandstrup, N., and Wang, I.: The lactic dehydrogenase, malic dehydrogenase and phosphoglucoisomerase activity of coronary artery tissue at various ages. J. Gerontol. , 13: 24, 1968.
4.
Kirk, J.E., and Sorenson, L.B.: The aldolase activity of aortic and pulmonary artery tissue. J. Gerontol., 11: 373, 1956.
5.
Med. World News: Lack of enzyme leads to atheroma . 2: 18, 1961.
6.
Kayatan, S.: Atherosclerosis and betaglucuronidase. Lancet, 2: 667, 1960.
7.
Altschul, R. : Einfluss von Cytochrome C auf serum cholesterin . Ztschr. Kreislaufforsch. , 48: 844, 1959 .
8.
Kask, E.: Metabolic enzymes in arteriosclerosis. Angiology, 13: 35, 1962.
9.
Hunter, J.D. : Nicotinic acid therapy in patients with coronary disease. New Zealand M. J., 59: 60, 1960.
10.
Clarke, N.E. : Atherosclerosis, occlusive vascular disease and E.D.T.A. Am. J. Cardiol., 6: 223, 1960.
11.
Fishmann, W.H. , Odell, L.D., Gill , J.E., and Christensen , R.A.: The influence of stilbesterol on serum betaglucuronidase in women following parturition . Am. J. Obst. & Gynec., 59: 414, 1950.
12.
Grundel, A. : Influence of enzyme treatment on sclerotic process. Die Medicin, 49: 2011, 1958.
13.
Wittermans, A.W.: Enzymatic therapy of general disorders in senility. Privat. Klin. und San., 6: 1, 1955.
14.
Bossy, A.: Clinical trial of an enzyme preparation in the treatment of arteriosclerosis . Praxis, 22: 575, 1961.
15.
Busohman, W. : Therapy of peripheral circulatory disturbance. Ztschr. sch. ges. Inn. Med., No. 15, 1959.
16.
Brouwer, M.: Experiences with a new drug in arteriosclerosis. Berlin , Gesund. No. 1, 1955.
17.
Fischer, E. : Verschrtenheim Dornholzhausen im Taunus Kranken und Kur Anstabt für Hirn un Rüchenmarks verlezte. Med. clin. , 15: 649, 1956.
18.
Fiegel, G., and Recknagel, K.: Ein Versuch enzymatischen Bef Beinfluzzung der hypertonie. Medizin, 31: 32, 1955.
19.
Hammerl, H. , and Klein, K.: The enzyme therapy of arteriosclerotic disease . Artzl. Forsch., 12: 300, 1959.
20.
Jaffe, H.L. , and Stein, E.: "Vasolastine in the treatment of Angina Pectoris ". J. Mt. Sinai Hosp., New York, 29 (3): 1962.
21.
Förster, B. : 12-Jahre Ehrfahrung mit Vasolastine. Med. Heute, 3: 92, 1964.
22.
Buschman, W. : Proceedings of Symposium on Drugs Affecting Lipid Metabolism, S. Garattini and R. Paoletti , Milan, 1960, p. 562.
23.
Thurner, A. , and Koch, J.: Determination of vascular elasticity and the enzyme therapy of arteriosclerosis. Helvet. med. acta , 24: 342, 1957.
24.
Mawdesley Thomas, L.E., and Rogerson , R.: The treatment of cerebral atherosclerosis with vasolastine. Brit. J. Clin. Pract., 18: 7, 1964.
25.
Rudlova, B. , and Diamant, J.: Vasolastine treatment in the neurotic symptoms of cerebral arteriosclerosis. Psychiat., 2: 85, 1963.
26.
Hoogerwerf, S.: Influence of vasolastine on artificially sclerosed rats. Genessk. gids., 33: 95, 1963.
27.
Mawdesley Thomas, L.E.: Enzyme therapy in experimentally produced atherosclerosis. Enzymologia, 31 (2): 5, 1966.
28.
De Haan, W. : The use of an enzyme preparation in small animal geriatrics. J. Small Animal Pract., 4: 123, 1966.
29.
Mayer Gros, W. , Slater, E., and Roth, M.: Clinical Psychiatry . Cassell, London, 1960.
30.
Brit. M. J.: Agents for lowering serum cholesterol . 2: 1181, 1964.
31.
Allison, R.S. : The Senile Brain. Arnold , London, 1962.
32.
Stengel, E.: Personal communication, 1965.
33.
Evans, P.: Relation of longstanding blood pressure levels to atherosclerosis . Lancet, 1: 516, 1965.
34.
Med. Tribune: Factors governing design of drug investigations. April 21, 13, 1966.
35.
Kho, T.K.: A study of the treatment of atherosclerosis cerebri with Vasolastine . University of Indonesia, Djakarta , 1965.
36.
Post, F.: The Clinical Psychiatry of Late Life. Pergamon Press, London, 1965.
37.
Anderson, F.W. : Practical Management of the Elderly. Blackwell, Oxford, 1967 .
38.
Barham Carter, A.: Cerebral Infarction. Pergamon Press, London, 1964.
39.
Saunders, J.P. : Lipotropic enzymes in treatment of atherosclerosis . Brit. J. Clin. Pract.,
